首页/数据集/Transcriptomic profiling predicting response to ustekinumab therapy in patients with Crohn's disease

Transcriptomic profiling predicting response to ustekinumab therapy in patients with Crohn's disease

ChEBI2023-10-31 更新2026-07-12 收录

炎症性肠病治疗

生物标志物研究

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-MTAB-7799 数据链接链接失效反馈

官方服务：

资源简介：

Transcriptomic profiling predicting response to ustekinumab therapy in patients with Crohn's disease

应用场景：

创建时间：

2023-10-31

相关数据集

mRNA Seq.zip

生物标志物研究

慢性萎缩性胃炎

The aim of the study is to explore biomarkers of intestinal metaplasia associated with chronic atrophic gastritis. Here is the raw data of DEGs via transcriptomics sequencing.

NIAID Data Ecosystem20

Data mining-based study of collagen type III alpha 1 (COL3A1) prognostic value and immune exploration in pan-cancer

生物标志物研究

肿瘤免疫浸润分析

The extracellular matrix (ECM) shows an essential effect during the occurrence and procession of human cancers. Type III collagen is a crucial component of ECM. Collagen Type III Alpha 1(COL3A1) is ab

NIAID Data Ecosystem20

Supplementary Table S15 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

卵巢癌免疫治疗

生物标志物研究

Supplementary Table S15. Clinical characteristics of patients with HGSC according to RB1 and BRCA status.

NIAID Data Ecosystem00

DataSheet_1_Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis.zip

肝癌早期预测

生物标志物研究

Hepatocellular carcinoma (HCC) is a common malignancy worldwide. Alpha-fetoprotein (AFP) is still the only serum biomarker widely used in clinical settings. However, approximately 40% of HCC patients

NIAID Data Ecosystem20

Dietary α-Eleostearic Acid Ameliorates Experimental Inflammatory Bowel Disease in Mice by Activating Peroxisome Proliferator-Activated Receptor-γ

PPARγ激动剂虚拟筛选

炎症性肠病治疗

BackgroundTreatments for inflammatory bowel disease (IBD) are modestly effective and associated with side effects from prolonged use. As there is no known cure for IBD, alternative therapeutic options

NIAID Data Ecosystem00